NEW YORK — South Korean electronics giant LG said Monday that its LG AI Research division has partnered with the Jackson Laboratory (Jax) to develop artificial intelligence-based technologies for predicting the efficacy of Alzheimer's disease therapies and for diagnosing cancer.
According to LG, Jax has developed mouse models with Alzheimer's disease-associated gene variants and mutations to investigate genetic characteristics of the condition throughout the mouse life cycle. The partners aim to use LG's AI Exaone platform to analyze data from such research to help personalize Alzheimer's disease treatment.
LG also said that it is collaborating with Jax to develop multimodal generative AI models that can rapidly diagnose cancer from pathology images and help predict treatment outcomes, as well as models that can interact with clinicians to guide healthcare decisions based on patients' individual genetics.
"We are thrilled to collaborate with LG AI Research to unleash the immense potential of AI in creating a data science bridge between humans and mouse models, which will advance our ability to predict human diseases and help in the development of new drugs and treatments," Charles Lee, scientific director of the Jackson Laboratory for Genomic Medicine, said in a statement.
Jax's alliance with LG follows the recent kickoff of an effort by the Farmington, Connecticut-based research institute to improve its management of data science activities and partnerships.